ACHV News and Press, Achieve Life Sciences Inc. From 06/29/21

ORCA-2 Designed to Assess the Efficacy and Safety of 3 mg Cytisinicline Three Times Daily Dosing Compared to Placebo in Adult Smokers in the United States SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 29, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceuti...

SeaChange International (SEAC) +26% on insider buying.ReTo Eco-Solutions (RETO) +21% after announcing new iron tailings project.Achieve Life Sciences (ACHV) +17%.Jiuzi Holdings, Inc. (JZXN) +15%.Tiziana Life Sciences PLC (TLSA) +11% on agreement with FHI Clinical to conduct Pha...

Achieve Life Sciences (ACHV) announces that the USPTO has allowed Patent Application No. 16/993,522 and Patent Application No. 17/101,686 covering the novel 3.0 mg three times daily ((TID)) cytisinicline dosing regimen. The allowed claims cover this dosing regimen and administration method fo...

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 3, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the Uni...

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / June 2, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced that the com...

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 27, 2021 / Achieve Life Sciences, Inc. (Nasdaq:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the closing ...

Gainers: Flanigan's Enterprises (BDL) +73%.Pieris Pharmaceuticals (PIRS) +48%.RYB Education (RYB) +27%.uCloudlink (UCL) +24%.Friedman Industries (FRD) +23%.Taiwan Liposome (TLC) +19%.Provention Bio (PRVB) +19%.The Joint (JYNT) +18%.New Oriental Education & Technology (EDU) +18%....

Achieve Life Sciences (ACHV) has priced its offering of ~2.86M common stock at $7/share for gross proceeds of ~$20M.Oppenheimer & Co. Inc. is acting as the sole book-running manager in connection with the offering.ACHV also has granted the underwriters a 30-day option to purchas...

SEATTLE, WA and VANCOUVER, BC / ACCESSWIRE / May 25, 2021 / Achieve Life Sciences, Inc. (NASDAQ:ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced the pricing ...

IAC/InterActiveCorp (IAC) -31%.Novan (NOVN) -18% on announcing 1-for-10 reverse stock split.Petros Pharmaceuticals (PTPI) -18%.Achieve Life Sciences (ACHV) -15% on proposing stock offeringLordstown Motors (RIDE) -13% on Q1 earnings releaseCreative Realities (CREX...